Literature DB >> 25043256

Up-regulation of the interferon-related genes in BRCA2 knockout epithelial cells.

Hong Xu1, Jian Xian, Emmanuelle Vire, Steven McKinney, Vivien Wei, Jason Wong, Rebecca Tong, Tony Kouzarides, Carlos Caldas, Samuel Aparicio.   

Abstract

BRCA2 mutations are significantly associated with early-onset breast cancer, and the tumour-suppressing function of BRCA2 has been attributed to its involvement in homologous recombination (HR)-mediated DNA repair. In order to identify additional functions of BRCA2, we generated BRCA2-knockout HCT116 human colorectal carcinoma cells. Using genome-wide microarray analyses, we have discovered a link between the loss of BRCA2 and the up-regulation of a subset of interferon (IFN)-related genes, including APOBEC3F and APOBEC3G. The over-expression of IFN-related genes was confirmed in different human BRCA2(-/-) and mouse Brca2(-/-) tumour cell lines, and was independent of senescence and apoptosis. In isogenic wild-type BRCA2 cells, we observed over-expression of IFN-related genes after treatment with DNA-damaging agents, and following ionizing radiation. Cells with endogenous DNA damage because of defective BRCA1 or RAD51 also exhibited over-expression of IFN-related genes. Transcriptional activity of the IFN-stimulated response element (ISRE) was increased in BRCA2 knockout cells, and the expression of BRCA2 greatly decreased IFNα-stimulated ISRE reporter activity, suggesting that BRCA2 directly represses the expression of IFN-related genes through the ISRE. Finally, the colony-forming capacity of BRCA2 knockout cells was significantly reduced in the presence of either IFNβ or IFNγ, suggesting that IFNs may have potential as therapeutic agents in cancer cells with BRCA2 mutations. The GEO Accession No. for microarray analysis is GSE54830.
Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  BRCA2; DNA damage; interferon

Mesh:

Substances:

Year:  2014        PMID: 25043256      PMCID: PMC4882165          DOI: 10.1002/path.4404

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  52 in total

1.  BRCA2 keeps Rad51 in line. High-fidelity homologous recombination prevents breast and ovarian cancer?

Authors:  Simon N Powell; Henning Willers; Fen Xia
Journal:  Mol Cell       Date:  2002-12       Impact factor: 17.970

Review 2.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

3.  The DNA damage response induces IFN.

Authors:  Sabrina Brzostek-Racine; Chris Gordon; Sarah Van Scoy; Nancy C Reich
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

4.  The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases.

Authors:  S B Lee; D Rodríguez; J R Rodríguez; M Esteban
Journal:  Virology       Date:  1997-04-28       Impact factor: 3.616

5.  Response of pancreatic cancer cells treated with interferon-alpha or beta and co-exposed to ionising radiation.

Authors:  Eva Jöst; Wynand P Roos; Bernd Kaina; Heinz Schmidberger
Journal:  Int J Radiat Biol       Date:  2010-09       Impact factor: 2.694

Review 6.  Developmental studies of Brca1 and Brca2 knock-out mice.

Authors:  R Hakem; J L de la Pompa; T W Mak
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

7.  Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.

Authors:  K A Foster; P Harrington; J Kerr; P Russell; R A DiCioccio; I V Scott; I Jacobs; G Chenevix-Trench; B A Ponder; S A Gayther
Journal:  Cancer Res       Date:  1996-08-15       Impact factor: 12.701

8.  Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.

Authors:  Juwon Lee; Amy Wang; Qiande Hu; Shan Lu; Zhongyun Dong
Journal:  Int J Oncol       Date:  2006-12       Impact factor: 5.650

9.  Cytokine expression and signaling in drug-induced cellular senescence.

Authors:  Z Novakova; S Hubackova; M Kosar; L Janderova-Rossmeislova; J Dobrovolna; P Vasicova; M Vancurova; Z Horejsi; P Hozak; J Bartek; Z Hodny
Journal:  Oncogene       Date:  2009-10-05       Impact factor: 9.867

10.  BRCA1 regulates IFN-gamma signaling through a mechanism involving the type I IFNs.

Authors:  Niamh E Buckley; Alison M Hosey; Julia J Gorski; James W Purcell; Jude M Mulligan; D Paul Harkin; Paul B Mullan
Journal:  Mol Cancer Res       Date:  2007-03       Impact factor: 5.852

View more
  9 in total

1.  Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours.

Authors:  Florian J Groelly; Manuela Porru; Jutta Zimmer; Hugo Benainous; Yanti De Visser; Anastasiya A Kosova; Serena Di Vito; Violeta Serra; Anderson Ryan; Carlo Leonetti; Alejandra Bruna; Annamaria Biroccio; Madalena Tarsounas
Journal:  EMBO Mol Med       Date:  2022-02-02       Impact factor: 12.137

2.  Identifying Biomarkers of Alzheimer's Disease via a Novel Structured Sparse Canonical Correlation Analysis Approach.

Authors:  Shuaiqun Wang; Yafei Qian; Kai Wei; Wei Kong
Journal:  J Mol Neurosci       Date:  2021-09-27       Impact factor: 3.444

3.  Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.

Authors:  Marie-Emmanuelle Legrier; Ivan Bièche; Julie Gaston; Arnaud Beurdeley; Vanessa Yvonnet; Olivier Déas; Aurélie Thuleau; Sophie Château-Joubert; Jean-Luc Servely; Sophie Vacher; Myriam Lassalle; Stéphane Depil; Gordon C Tucker; Jean-Jacques Fontaine; Marie-France Poupon; Sergio Roman-Roman; Jean-Gabriel Judde; Didier Decaudin; Stefano Cairo; Elisabetta Marangoni
Journal:  Br J Cancer       Date:  2015-12-22       Impact factor: 7.640

4.  CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.

Authors:  Hong Xu; Marco Di Antonio; Steven McKinney; Veena Mathew; Brandon Ho; Nigel J O'Neil; Nancy Dos Santos; Jennifer Silvester; Vivien Wei; Jessica Garcia; Farhia Kabeer; Daniel Lai; Priscilla Soriano; Judit Banáth; Derek S Chiu; Damian Yap; Daniel D Le; Frank B Ye; Anni Zhang; Kelsie Thu; John Soong; Shu-Chuan Lin; Angela Hsin Chin Tsai; Tomo Osako; Teresa Algara; Darren N Saunders; Jason Wong; Jian Xian; Marcel B Bally; James D Brenton; Grant W Brown; Sohrab P Shah; David Cescon; Tak W Mak; Carlos Caldas; Peter C Stirling; Phil Hieter; Shankar Balasubramanian; Samuel Aparicio
Journal:  Nat Commun       Date:  2017-02-17       Impact factor: 14.919

5.  PARP1 depletion induces RIG-I-dependent signaling in human cancer cells.

Authors:  Rajib Ghosh; Sanchita Roy; Sonia Franco
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

6.  BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial Cells.

Authors:  Julia Hollingsworth; Angela Lau; Alicia Tone; Alexandra Kollara; Lisa Allen; Terence J Colgan; Valerie Dube; Barry Rosen; K Joan Murphy; Ellen M Greenblatt; Tomer Feigenberg; Carl Virtanen; Theodore J Brown
Journal:  Neoplasia       Date:  2018-05-28       Impact factor: 5.715

7.  BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors.

Authors:  Timo Reisländer; Emilia Puig Lombardi; Florian J Groelly; Ana Miar; Manuela Porru; Serena Di Vito; Benjamin Wright; Helen Lockstone; Annamaria Biroccio; Adrian Harris; Arturo Londoño-Vallejo; Madalena Tarsounas
Journal:  Nat Commun       Date:  2019-07-17       Impact factor: 14.919

8.  Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.

Authors:  Eliana Mc Tacconi; Sophie Badie; Giuliana De Gregoriis; Timo Reisländer; Xianning Lai; Manuela Porru; Cecilia Folio; John Moore; Arnaud Kopp; Júlia Baguña Torres; Deborah Sneddon; Marcus Green; Simon Dedic; Jonathan W Lee; Ankita Sati Batra; Oscar M Rueda; Alejandra Bruna; Carlo Leonetti; Carlos Caldas; Bart Cornelissen; Laurent Brino; Anderson Ryan; Annamaria Biroccio; Madalena Tarsounas
Journal:  EMBO Mol Med       Date:  2019-05-24       Impact factor: 12.137

9.  The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells.

Authors:  Kimberly C Olney; David B Nyer; Daniel A Vargas; Melissa A Wilson Sayres; Karmella A Haynes
Journal:  BMC Syst Biol       Date:  2018-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.